BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23238483)

  • 1. Modification of morphine analgesia by venlafaxine in diabetic neuropathic pain model.
    Cegielska-Perun K; Bujalska-Zadrożny M; Makulska-Nowak HE
    Pharmacol Rep; 2012; 64(5):1267-75. PubMed ID: 23238483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of antinociceptive effect of morphine by antidepressants in diabetic neuropathic pain model.
    Cegielska-Perun K; Bujalska-Zadrożny M; Gąsińska E; Makulska-Nowak HE
    Pharmacol Rep; 2014 Apr; 66(2):228-34. PubMed ID: 24911074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats.
    Ozdemir E; Gursoy S; Bagcivan I
    J Physiol Sci; 2012 Jul; 62(4):317-23. PubMed ID: 22544464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of morphine-venlafaxine interactions in diabetic neuropathic pain model.
    Cegielska-Perun K; Tatarkiewicz J; Siwek A; Dybała M; Bujalska-Zadrożny M
    Pharmacol Rep; 2015 Feb; 67(1):90-6. PubMed ID: 25560581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selol on the opioids activity in streptozotocin induced hyperalgesia.
    Bujalska M; Winecka R; Gumułka SW
    Acta Pol Pharm; 2008; 65(6):691-6. PubMed ID: 19172850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia.
    Bujalska M; Malinowska E; Makulska-Nowak H; Gumułka SW
    Pharmacology; 2008; 82(3):180-6. PubMed ID: 18701828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic effects of antidepressants alone and after their local co-administration with morphine in a rat model of neuropathic pain.
    Jagla G; Mika J; Makuch W; Obara I; Wordliczek J; Przewlocka B
    Pharmacol Rep; 2014 Jun; 66(3):459-65. PubMed ID: 24905524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term administration of fluvoxamine attenuates neuropathic pain and involvement of spinal serotonin receptors in diabetic model rats.
    Kato T; Kajiyama S; Hamada H; Kawamoto M
    Hiroshima J Med Sci; 2013 Dec; 62(4):83-9. PubMed ID: 24597211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of morphine dependence and withdrawal in rats by venlafaxine, a serotonin and noradrenaline reuptake inhibitor.
    Lu L; Su WJ; Yue W; Ge X; Su F; Pei G; Ma L
    Life Sci; 2001 May; 69(1):37-46. PubMed ID: 11411809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide Promotes Morphine Efficacy and Prevents Morphine-Induced Tolerance in Rats with Diabetic Neuropathy.
    Zhao J; Wang H; Song T; Yang Y; Gu K; Ma P; Zhang Z; Shen L; Liu J; Wang W
    Neurochem Res; 2016 Dec; 41(12):3171-3180. PubMed ID: 27573481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of morphine antinociception and inhibition of diabetic neuropathic pain by the multi-chemokine receptor antagonist peptide RAP-103.
    Ruff MR; Inan S; Shi XQ; Meissler JJ; Adler MW; Eisenstein TK; Zhang J
    Life Sci; 2022 Oct; 306():120788. PubMed ID: 35817166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Antihyperalgesic and Opioid-Sparing Effects of 5-Day Ketamine and Morphine Infusion ("Burst Ketamine") in Diabetic Neuropathic Rats.
    Mak P; Broadbear JH; Kolosov A; Goodchild CS
    Pain Med; 2015 Sep; 16(9):1781-93. PubMed ID: 25800174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venlafaxine and neuropathic pain.
    Cegielska-Perun K; Bujalska-Zadrożny M; Tatarkiewicz J; Gąsińska E; Makulska-Nowak HE
    Pharmacology; 2013; 91(1-2):69-76. PubMed ID: 23183148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy.
    Kiguchi S; Imamura T; Ichikawa K; Kojima M
    Clin Exp Pharmacol Physiol; 2004; 31(1-2):57-64. PubMed ID: 14756685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tapentadol increases levels of noradrenaline in the rat spinal cord as measured by in vivo microdialysis.
    Tzschentke TM; Folgering JH; Flik G; De Vry J
    Neurosci Lett; 2012 Jan; 507(2):151-5. PubMed ID: 22197547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats.
    Taliyan R; Sharma PL
    Inflammopharmacology; 2012 Apr; 20(2):89-97. PubMed ID: 22179948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects--a possible opioid involvement in severe depression?
    Schreiber S; Bleich A; Pick CG
    J Mol Neurosci; 2002; 18(1-2):143-9. PubMed ID: 11931344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
    Christoph T; De Vry J; Tzschentke TM
    Neurosci Lett; 2010 Feb; 470(2):91-4. PubMed ID: 20026182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.
    Filip M; Wydra K; Inan SY; Dziedzicka-Wasylewska M; Przegaliński E
    Eur J Pharmacol; 2004 Sep; 498(1-3):143-51. PubMed ID: 15363988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the opioidergic system and nitric oxide in the analgesic effect of venlafaxine.
    Gültekin H; Ahmedov V
    Yakugaku Zasshi; 2006 Feb; 126(2):117-21. PubMed ID: 16462101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.